Mubadala to invest in Germany’s ophthalmic lens manufacturer Rodenstock | The National
Mubadala Investment Company is investing in Germany’s Rodenstock Group, a premium ophthalmic lenses manufacturer, as it continues to expand its global medical technology and life sciences portfolio.
Abu Dhabi's strategic investment arm will take a minority stake in Rodenstock along with funds advised by British equity firm Apax Partners, the company said in a statement on Sunday. It did not disclose the size of the stake or financial details of the deal.
The transaction is subject to regulatory approvals and is expected to close in the middle of 2021, Mubadala said.
Rodenstock has a "reputation for innovation and a consistent focus on offering a differentiated customer proposition”, Camilla Macapili Languille, head of life sciences at Mubadala, said.
“We see its highly customised biometric lenses as only one part of its growing pipeline of proprietary technologies that will enable significant future growth.”
No comments:
Post a Comment